Endoret® (PRGF®) is a 100 % endogenous technology, based on platelet-enriched plasma obtained from patient’s own blood. The high regenerative potential and versatility make Endoret® (PRGF®) a MUST for a wide range of clinical applications.
The perfect smile is the result of a series of successful prosthodontic decisions in terms of the design, techniques and fabrication materials of dental prostheses.
NEW BTI APNIA - a simplified and efficient system for the diagnosis and treatment of sleep apnoea and snoring
The new BTI Apnia electronic device, due to its design and functionality, tops the list of the most simplified respiratory polygraphs on the market.
BTI Biotechnology Institute proposes a minimally invasive alternative for this surgical treatment: the new family of 3.0 implants
More and more scientific studies are revealing the predictability of immediate loaded short implants. Thus, the development by BTI® of a series of surgical-prosthetic concepts, resulting in a protocol that uses short implants, front cutting drills and Multi – Im® transepithelial abutments enables the execution, with better results, of the immediate loading technique in multiple restorations
BTI Biotechnology Institute is the pioneering company leading the market in the development of tissue regeneration techniques through the therapeutic use of plasma rich in growth factors.
Intended for international use only. Indications for use of products and/or therapies contained herein may not be cleared /approved for use by the following Health international agencies: US Food & Drug Administration, Health Canada or Japanese Health Ministry. To access the specific information of your market, use the country selector located on the top menu of this page.